Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis

NCT04664153 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis
Plaque Psoriasis

Interventions

DRUG: PF-07038124 ointment
DRUG: Vehicle ointment

Sponsor

Pfizer